- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02711839
Evaluation of White Sweet Potato Tube Feeding Formula on Type 2 Diabetic Residents in Long-term Care Institutions
April 9, 2019 updated by: Taipei Medical University
Office of Human Research, Taipei Medical University
In order to response the increasing of aging population cause losing ability that need long-care needs, the project entitled "10-year long-term care program" from Executive Yuan in 2007 is carried out to assist economically disadvantaged and disabled elderly to acquire daily nutrition.
Therefore, the long-term care resident's nutritional status got more attention than before.
Out of control in blood glucose will not only increase bed sores and urinary tract infection in tube feeding residents but also rise medical expenditures.
The nutritional status of long-term care institutions, anyang homes and nursing home are generally bad in nutrition management due to high cost of nutritional supplements from foreign imports that cause the burden of families.
In this study, we will recruit diabetic subjects that divide into white sweet potato group (experimental group) and commercial formula group (control group) by using randomized, parallel and open clinical study through tube feeding in sixty days.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
All subjects will be evaluated the blood sugar and clinical nutrition assessment such as postural measurement, urine test and blood biomarker examination.
Study Type
Interventional
Enrollment (Actual)
54
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Long-term stability nasogastric or gastrostomy-fed person.
- The physician diagnosed as diabetic and regular use of hypoglycemic drugs.
Exclusion Criteria:
- Psychosis or depression.
- Hba1c> 8.5%.
- High taking nutritional supplements or steroids drugs.
- Have undergone abdominal surgery caused by intestinal sticky.
- Suffering from cancer, ulcers, respiratory infections and other diseases.
- Currently receiving central venous nutrition therapy or intravenous nutrition therapy.
- Liver dysfunction (ALT ≧ 100 U / L), renal insufficiency (creatinine ≧ 3mg / dl), heart failure (NYFc II above), moderate anemia (hemoglobin <9 g / dl).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Control Group
Commercial diabetic formula
|
The formula were supplied 1500~1800 kcal daily depend on the patient's individual situation
Other Names:
|
Experimental: Treatment Group
White sweet potato formula
|
The formula were supplied 1500~1800 kcal daily depend on the patient's individual situation
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
HbA1c After Intervention
Time Frame: 60 days
|
HbA1c value after 60 days intervention in both groups
|
60 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Albumin After Intervention
Time Frame: 60 days
|
Albumin value after 60 days intervention in both groups
|
60 days
|
Glucose After Intervention
Time Frame: 60 days
|
Glucose value after 60 days intervention in both groups
|
60 days
|
Total Cholesterol After Intervention
Time Frame: 60 days
|
Total cholesterol value after 60 days intervention in both groups
|
60 days
|
Triglyceride After Intervention
Time Frame: 60 days
|
Triglyceride value after 60 days intervention in both groups
|
60 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Ooi CP, Loke SC. Sweet potato for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2013 Sep 3;2013(9):CD009128. doi: 10.1002/14651858.CD009128.pub3.
- Chen CM, Shih CK, Su YJ, Cheang KU, Lo SF, Li SC. Evaluation of white sweet potato tube-feeding formula in elderly diabetic patients: a randomized controlled trial. Nutr Metab (Lond). 2019 Oct 16;16:70. doi: 10.1186/s12986-019-0398-8. eCollection 2019.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2015
Primary Completion (Actual)
November 1, 2016
Study Completion (Actual)
December 1, 2016
Study Registration Dates
First Submitted
November 17, 2015
First Submitted That Met QC Criteria
March 13, 2016
First Posted (Estimate)
March 17, 2016
Study Record Updates
Last Update Posted (Actual)
July 1, 2019
Last Update Submitted That Met QC Criteria
April 9, 2019
Last Verified
May 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- 201505027
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes
-
Antonio Di MauroCompletedType-2 DiabetesItaly
-
DiaMedica Therapeutics IncCompletedDiabetes Type 2Netherlands
-
RenJi HospitalUnknownType 2 Diabetes.China
-
University of Erlangen-Nürnberg Medical SchoolCompletedType 2-diabetesGermany
-
Chengdu Brilliant Pharmaceutical Co., Ltd.Not yet recruitingType 2 Diabetes Mellitus
-
Nanjing First Hospital, Nanjing Medical UniversityRecruitingType 2 Diabetes MellitusChina
-
Xiangya Hospital of Central South UniversityRecruitingType 2 Diabetes MellitusChina
-
University of Alabama at BirminghamCompletedType 2 Diabetes MellitusUnited States
-
Imperial College LondonAstraZeneca; Huma; North West London Collaboration of CCGs (NWL CCGs); Imperial...CompletedType 2 Diabetes MellitusUnited Kingdom
-
Universiti Sains MalaysiaCompleted
Clinical Trials on Commercial diabetic formula
-
Jovie USA, LLCIQVIA RDS Inc.; ObvioHealthCompleted
-
Bobbie Baby, IncRecruitingHealthy GrowthUnited States
-
Fundació Sant Joan de DéuNot yet recruitingInfant Growth | Childhood Overweight
-
Chang Gung Memorial HospitalCompletedHyperglycemia | Thoracic Injury | Abdominal Injury | Hyperglycemia StressTaiwan
-
University of OxfordCompletedHealthy Volunteers | Chuvash PolycythaemiaUnited Kingdom
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityNot yet recruiting
-
HiPP GmbH & Co. Vertrieb KGCharite University, Berlin, GermanyCompletedDisturbance of GrowthGermany, Austria, Serbia
-
Rosalind Franklin University of Medicine and ScienceMadigan Army Medical CenterCompleted
-
HiPP GmbH & Co. Vertrieb KGTerminatedInfantile ColicGermany, Italy
-
Institut de Cancérologie de LorraineCompletedBladder CancerFrance